Literature DB >> 32643520

Seroprevalence survey for Varicella among healthcare workers and medical students in Italy.

Ottavia Balbi1, Savino Baldi1, Stefano Rizza2, Antonio Pietroiusti1, Stefano Perrone1, Luca Coppeta1.   

Abstract

Varicella is a potentially serious infectious disease caused by Varicella-Zoster Virus (VZV). In Italy childhood varicella vaccine have gradually introduced into national immunization program since 2003 and from 2017 a two-doses schedule has been stated nationally for all newborns and has become compulsory for school attendance. VZV exposures among healthcare workers (HCWs) and patients can be really dangerous and expensive. According to Centers of Disease Control and Italian national immunization plan health care, institutions should verify that all HCWs have clear evidence of immunity to VZV and should ensure that susceptible subjects will receive 2 doses of VZV vaccine. Currently, the vaccination of HCWs is not compulsory in Italy and the risk of varicella infection among these subjects is not well known. We evaluated the clinical records of 840 HCWs (256 male and 584 female) who underwent the annual occupational screening, from 1st January to 31st August 2018. HCWs were divided into three subgroups according to their age: 18-30, 31-40, and over 40 years old. We compared the mean values of IgG-specific antibodies between the age group through analysis of variance (ANOVA). A total of 784 (93.33%) HCWs were protected for VZV IgG antibodies level. There wasn't a significant difference between male and female while was found between age group (P < 0.001). Protection levels for varicella are inadequate among HCWs. Despite the epidemiology of varicella in general population has changed with the implementation of the childhood varicella vaccination program transmission of VZV in hospitals is still a serious problem, so it is necessary to increase prevention activities in these settings, including vaccination.

Entities:  

Keywords:  Occupational epidemiology; healthcare workers; infection; varicella; varicella vaccination

Year:  2020        PMID: 32643520      PMCID: PMC7899655          DOI: 10.1080/21645515.2020.1771989

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  29 in total

1.  Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan.

Authors:  Seishi Asari; Matsuo Deguchi; Kazuko Tahara; Masako Taniike; Masahiro Toyokawa; Isao Nishi; Mikio Watanabe; Yoshinori Iwatani; Kiyoko Makimoto
Journal:  Am J Infect Control       Date:  2003-05       Impact factor: 2.918

Review 2.  Prevention and control of varicella-zoster infections in healthcare facilities.

Authors:  D J Weber; W A Rutala; H Hamilton
Journal:  Infect Control Hosp Epidemiol       Date:  1996-10       Impact factor: 3.254

3.  An outbreak of varicella in staff nurses exposed to a patient with localized herpes zoster.

Authors:  Lisa Saidel-Odes; Abraham Borer; Klaris Riesenberg; Amit Frenkel; Roslan Sherlis; Leah Bouhnick; Fransisc Schlaeffer
Journal:  Scand J Infect Dis       Date:  2010-08

4.  Has VZV epidemiology changed in Italy? Results of a seroprevalence study.

Authors:  Antonella De Donno; Parvanè Kuhdari; Marcello Guido; Maria Cristina Rota; Antonino Bella; Giordana Brignole; Silvia Lupi; Adele Idolo; Armando Stefanati; Martina Del Manso; Giovanni Gabutti
Journal:  Hum Vaccin Immunother       Date:  2016-12-27       Impact factor: 3.452

5.  Persistence of immunity to live attenuated varicella vaccine in healthy adults.

Authors:  Krow Ampofo; Lisa Saiman; Philip LaRussa; Sharon Steinberg; Paula Annunziato; Anne Gershon
Journal:  Clin Infect Dis       Date:  2002-02-04       Impact factor: 9.079

Review 6.  Varicella-zoster virus: overview and clinical manifestations.

Authors:  A M Arvin
Journal:  Semin Dermatol       Date:  1996-06

Review 7.  Varicella zoster virus infection.

Authors:  Anne A Gershon; Judith Breuer; Jeffrey I Cohen; Randall J Cohrs; Michael D Gershon; Don Gilden; Charles Grose; Sophie Hambleton; Peter G E Kennedy; Michael N Oxman; Jane F Seward; Koichi Yamanishi
Journal:  Nat Rev Dis Primers       Date:  2015-07-02       Impact factor: 52.329

8.  Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015.

Authors:  Thorsten Rieck; Marcel Feig; Matthias An der Heiden; Anette Siedler; Ole Wichmann
Journal:  Euro Surveill       Date:  2017-04-27

9.  The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting.

Authors:  Christophe Sauboin; Katsiaryna Holl; Paolo Bonanni; Anne A Gershon; Bernd Benninghoff; Stephane Carryn; Margaret A Burgess; Peter Wutzler
Journal:  BMC Infect Dis       Date:  2019-02-06       Impact factor: 3.667

10.  Varicella seroprevalence in healthcare workers in a tertiary hospital: an audit of cross-sectional data.

Authors:  Alexander Wilhelm Gorny; Chikul Mittal; Sharon Saw; Indumathi Venkatachalam; Dale Andrew Fisher; Paul Anantharajah Tambyah
Journal:  BMC Res Notes       Date:  2015-11-10
View more
  1 in total

1.  Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study.

Authors:  Francesco Paolo Bianchi; Silvio Tafuri; Angela Maria Vittoria Larocca; Cinzia Annatea Germinario; Pasquale Stefanizzi
Journal:  BMC Infect Dis       Date:  2021-05-25       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.